These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4473893)

  • 1. Postnatal lead acetate exposure in rats: possible relationship to minimal brain dysfunction.
    Sobotka TJ; Cook MP
    Am J Ment Defic; 1974 Jul; 79(1):5-9. PubMed ID: 4473893
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of monkeys asphyxiated at birth: implications for minimal cerebral dysfunction.
    Sechzer JA; Faro MD; Windle WF
    Semin Psychiatry; 1973 Feb; 5(1):19-34. PubMed ID: 4215138
    [No Abstract]   [Full Text] [Related]  

  • 3. [Levels of lead in children with hyperactivity and attention deficits. Response to the administration of D-penicillamine].
    Montoya-Cabrera MA; Sauceda-García JM; López-Martín G; Falcón-Díaz O; Rodríguez-Blanca MC
    Bol Med Hosp Infant Mex; 1985 Feb; 42(2):88-91. PubMed ID: 3986035
    [No Abstract]   [Full Text] [Related]  

  • 4. Attention deficit hyperactivity disorder, infantile autism, and elevated blood-lead: a possible relationship.
    Eppright TD; Sanfacon JA; Horwitz EA
    Mo Med; 1996 Mar; 93(3):136-8. PubMed ID: 8867271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of a postnatal alcohol-induced deficit in learned persistence in the rat by d-amphetamine.
    Highfield DA; Lilliquist MW; Amsel A
    Alcohol Clin Exp Res; 1999 Jun; 23(6):1094-101. PubMed ID: 10397296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of neurotensin microinjected into ventral tegmental area on spontaneous motor activity in neonatal 6-hydroxydopamine-treated rats].
    Ikegami M; Iwasaki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):83-5. PubMed ID: 15164616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects of moderate lead exposure in children and animal models: part 2, animal studies.
    Bornschein R; Pearson D; Reiter L
    Crit Rev Toxicol; 1980 Dec; 8(2):101-52. PubMed ID: 7002475
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions.
    Zhang K; Davids E; Tarazi FI; Baldessarini RJ
    Psychopharmacology (Berl); 2002 Apr; 161(1):100-6. PubMed ID: 11967637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early behavioral effects of lead perinatal exposure in rat pups.
    De Marco M; Halpern R; Barros HM
    Toxicology; 2005 Jul; 211(1-2):49-58. PubMed ID: 15863247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal lead exposure in rats: I. Effects on activity and brain metals.
    McCarren M; Eccles CU
    Neurobehav Toxicol Teratol; 1983; 5(5):527-31. PubMed ID: 6686650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D; Bayer L; Strupp BJ
    Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead-induced behavioral disorders in the rat: effects of amphetamine.
    Kostas J; McFarland DJ; Drew WG
    Pharmacology; 1978; 16(4):226-36. PubMed ID: 634997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurologic learning disability syndrome.
    Silver LB
    Am Fam Physician; 1971 Jul; 4(1):95-102. PubMed ID: 4934540
    [No Abstract]   [Full Text] [Related]  

  • 14. The neonatal rat as a developmental animal model of attention deficit hyperactivity disorder: Effects of frontal lesions on activity and learning.
    Mietus BA; Johanson IB; Terry LM
    Dev Psychobiol; 2003 Jan; 42(1):79-90. PubMed ID: 12471638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies regarding low blood lead level harm.
    O'Dowd P
    Med Health R I; 2002 Nov; 85(11):345-8. PubMed ID: 12462867
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxicological considerations in the assessment of lead exposure.
    Hammond PB; Bornschein RL; Zenick H
    Neurotoxicology; 1984; 5(3):53-66. PubMed ID: 6395050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Minimal organic brain dysfunction in infantile psychiatry].
    Scarcella M
    Recenti Prog Med; 1972 May; 52(5):464-82. PubMed ID: 4677777
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of pre-natal and continued lead exposure on activity levels in the mouse.
    Zimering RT; Burright RG; Donovick PJ
    Neurobehav Toxicol Teratol; 1982; 4(1):9-14. PubMed ID: 7070574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness to d-amphetamine in lead-exposed rats as measured by steady state levels of catecholamines and locomotor activity.
    Rafales LS; Greenland RD; Zenick H; Goldsmith M; Michaelson IA
    Neurobehav Toxicol Teratol; 1981; 3(3):363-7. PubMed ID: 7290291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal brain dysfunction. Introduction.
    Walzer S; Richmond JB
    Semin Psychiatry; 1973 Feb; 5(1):1-3. PubMed ID: 4139758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.